Evidence map›Paper›PMID 38279757›Full record

SynthesisMedicinal chemistry (Shariqah (United Arab Emirates))2024

Recent Advances in Nitrogen-Containing Heterocyclic Scaffolds as Antiviral Agents.

Kanupriya, Ravi Kumar Mittal, Vikram Sharma, Tanya Biswas, Isha Mishra

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Medicinal chemistry (Shariqah (United Arab Emirates)), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Recyclable CaSiOChemistry, an Asian journal · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

KanupriyaGalgotias College of Pharmacy, Greater Noida, Uttar Pradesh, 201310, India.
Ravi Kumar MittalGalgotias College of Pharmacy, Greater Noida, Uttar Pradesh, 201310, India.ORCID 0000-0001-8234-2466
Vikram SharmaGalgotias College of Pharmacy, Greater Noida, Uttar Pradesh, 201310, India.
Tanya BiswasGalgotias College of Pharmacy, Greater Noida, Uttar Pradesh, 201310, India.
Isha MishraGalgotias College of Pharmacy, Greater Noida, Uttar Pradesh, 201310, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to provide a thorough analysis of nitrogen-containing heterocycles, focusing on their therapeutic implications for the development of targeted and effective antiviral drugs. To better understand how nitrogen-containing heterocycles can be used to create antiviral drugs, this review adopts a systematic literature review strategy to compile and analyze pertinent research studies. It combines information from various fields to understand better the compounds' mode of action and their therapeutic potential. This review paper summarizes data from multiple sources to highlight the promising potential of heterocycles containing nitrogen as promising possibilities for future antiviral treatments. The capacity to engage selectively and modulate critical pathways bodes well for their use in developing new viral therapies. In conclusion, nitrogen-containing heterocycles are shown to be of utmost importance in the field of medicinal chemistry, as emphasized by the review paper. It emphasizes the central importance of chemical insights and pharmacological potential in developing novel and effective antiviral medicines by bringing them together.

Indexed as

Antiviral AgentsHeterocyclic CompoundsNitrogenAnimalsHumansAntiviral AgentsHeterocyclic CompoundsNitrogenantiviralbenzimidazoleHeterocyclespyrazolepyrimidinequinolinethiadiazol

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.